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n 2007 and 2008, the World Health Organization's De-
partment for Child and Adolescent Health and Devel-
opment (later renamed as WHO MNCAH – Maternal, 
Newborn, Child and Adolescent Health) commissioned 
five large exercises to define research priorities related to 
the five major causes of child deaths for the period up to 
the year 2015. The exercises were based on the CHNRI 
(Child Health and Nutrition Research Initiative) method, 
which was just being introduced at the time [1,2]. The se-
lected causes were childhood pneumonia, diarrhoea, birth 
asphyxia, neonatal infections and preterm birth/low birth 
weight [3–7]. The context for those exercises was clearly 
defined: to identify research that could help reduce mor-
tality in children under 5 years of age in low and middle 
income countries by the year 2015. The criteria used in all 
five exercises were the “standard” CHNRI criteria: (i) an-
swerability of the research question; (ii) likelihood of the 
effectiveness of the resulting intervention; (iii) deliverabil-
ity (with affordability and sustainability); (iv) potential to 
reduce disease burden; and (v) effect on equity [3–7].
The five criteria used by the scorers were intuitive as they 
followed the path from generating new knowledge to hav-
ing an impact on the cause of death. They were chosen with 
a view to identifying research questions that were most 
likely to contribute to finding effective solutions to the 
problems. However, after the five exercises – all of which 
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were published in respected international journals [3–7] 
– the WHO officers were left with an additional question: 
how “fundable” were the identified priorities, ie, how at-
tractive were they to research funders? More specifically, 
should another criterion be added to the CHNRI exercises, 
which would evaluate the likelihood of obtaining funding 
support for specific research questions?
To answer these questions, coordinators of the CHNRI ex-
ercises at the WHO agreed that it would be useful to invite 
a number of representatives from large funding organiza-
tions interested in child health research to take part in a 
consultation process at the WHO. The process aimed to 
explore funders' perspective in prioritization of health re-
search. The funders would be presented with the leading 
research priorities identified through the CHNRI exercises 
and asked to discuss any potential variation in their likeli-
hood of being funding. If all the leading priorities were 
equally attractive to funders and likely to attract funding 
support, this would indicate that the “standard” CHNRI 
criteria were sufficient for the process of prioritization. 
However, if there were large differences in attractiveness of 
the identified research priorities to funders, then adding 
another criterion to the exercise – “likelihood of obtaining 
funding support”, or simply “fundability” – would be a use-
ful addition to the standard CHNRI framework.
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THE MEETING WITH THE FUNDERS 
(GENEVA, 27–29 MARCH 2009)
In March 2009, MNCAH invited 40 representatives from 
funding organizations, including the Bill and Melinda 
Gates Foundation, the Wellcome Trust, National Institutes 
of Health USA, Department for International Development 
UK, Save the Children, INCLEN, EPICENTRE, UNICEF, 
USAID, PATH, Ministry of Science and Technology of In-
dia, Ministries of Health of Zambia, Pakistan and Brazil, 
Global Forum for Health Research, Trinity Global Support 
Foundation, Children's Investment Fund Foundation, Osa-
ka Research Institute for Maternal and Child Health. Even-
tually, 16 representatives of funding agencies agreed to take 
part in the exercise under the condition of anonymity. 
Moreover, it was understood that their input would not 
necessarily be the official position of their respective fund-
ing agencies, nor would it create any form of funding ob-
ligation.
Having explained the aims of the consultation meeting to 
the representatives of funding agencies, the 16 participants 
were presented with a list of the top 10 research priorities 
for each of the five major causes of child deaths: pneumo-
nia, diarrhea, birth asphyxia, neonatal infections and pre-
term birth/low birth weight [3–7]. This set of 50 research 
priorities represented roughly the top 5% of all the research 
ideas submitted for scoring during the CHNRI exercises. 
The WHO coordinators (RB and JM) explained each of the 
50 leading research priorities to the 16 donor representa-
tives. Then, the 16 donor representatives were provided 
with the list of research priorities and asked to individu-
ally identify those that were most likely to receive funding 
support from their respective organizations.
Funding attractiveness was measured in two ways. First, 
funder representatives were asked to rank the identified 
research priorities according to their likelihood to receive 
funding support under an organization’s current invest-
ment policies and practices. Second, funding attractiveness 
was measured by asking funder representatives to distrib-
ute a theoretical US$ 100 among the research priorities that 
seem most fundable. Results were used to facilitate discus-
sion on what makes a research question attractive (or un-
attractive) for funding support. The scoring sheet that was 
given to meeting participants is shown in Figure 1. While 
they did not need to provide their name or organization, 
they were asked to assign ranks 1–10 to the ten research 
priorities identified for each of the five causes of death (col-
umn 1), and also to distribute a hypothetical US$ 100 to 
different research priorities in concordance to the likely 
funding support that they may obtain.
Sixteen participants scored the identified research priori-
ties according to the instructions (Figure 1). The average 
ranks across the 16 participants (1 = most likely to be fund-
ed; 10 = least likely to be funded) assigned to the 50 re-
search priorities ranged from 3.7 to 7.2. The average US$ 
amount assigned to research priorities ranged from US$ 
20.1 to US$ 2.5. There was general consistency between 
ranks and the US$ assigned to research priorities.
In 2007 and 2008, the World Health Organiza-
tion's Department for Child and Adolescent 
Health and Development commissioned five 
large research priority setting exercises using 
the CHNRI (Child Health and Nutrition Re-
search Initiative) method. The aim was to de-
fine research priorities related to the five ma-
jor causes of child deaths for the period up to 
the year 2015. The selected causes were child-
hood pneumonia, diarrhoea, birth asphyxia, 
neonatal infections and preterm birth/low 
birth weight. The criteria used for prioritiza-
tion in all five exercises were the “standard” 
CHNRI criteria: answerability, effectiveness, 
deliverability, potential for mortality burden 
reduction and the effect on equity. Having 
completed the exercises, the WHO officers 
were left with another question: how “fund-
able” were the identified priorities, i.e. how 
attractive were they to research funders?
Figure 1. A questionnaire that was given to 16 funder represen-
tatives at the meeting to obtain information useful to under-
standing funding attractiveness of different research priorities.
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Importantly, the analysis of the collective input based on 
the 2nd column (ie, assigned US$), presented in Figure 2, 
clearly shows that there was a rather substantial departure 
of the assigned funds from that expected at random: if all 
research priorities were equally likely to obtain support 
from the funders, then all the bars would be extending only 
to the line that represents an investment of US$ 10.0. Fur-
thermore, 4 research priorities (8%) clearly stood out from 
the rest [8]. It was agreed that they might provide a start-
ing point from which MNCAH Department could concen-
trate its efforts. These 4 research priorities are shown in 
Table 1.
Table 1. The 4 research priorities (8%) that were identified as 
positive outliers in terms of their likelihood to obtain funding 
support
 Evaluate the quality of community workers to adequately assess, recog-
nize danger signs, refer and treat acute respiratory infections (ARI) in 
different contexts and settings.
What are the barriers against appropriate use of oral rehydration therapy?
What are the feasibility, effectiveness and cost of different approaches to 
promote the following home care practices (breastfeeding, cord/skin, 
care seeking, handwashing)?
What are the feasibility, effectiveness and cost of a scheme of routine 
home visits for initiation of supportive practices, detection of illness and 
newborn survival?
Figure 2. The results of the collective input from 16 funder representatives, showing large differences in funding attractiveness 
between 50 research priorities. No substantial differences in funding attractiveness would be indicated by equality of the scores on 
the horizontal axis at the US$ 10.0 line.
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AN ANALYSIS OF THE EXERCISE WITH 
FUNDER REPRESENTATIVES
The results were analysed after the first day of the meeting 
and presented to donor representatives at the beginning of 
the second day of the meeting. An open discussion was 
held with participants to understand and interpret the re-
sults of their collective input. Participants agreed that the 
most important criteria for research prioritisation differed 
between researchers and funders. Researchers tended to 
value answerability, effectiveness, deliverability, impact on 
the burden and equity. Funders were also interested in the 
clarity and specificity of research ideas, value for money, 
novelty, international competitiveness of the groups pro-
posing the research, linkages to broader societal issues, and 
complementarity with other long–term strategic invest-
ments that were already made. An important point in the 
discussion was that researchers and research funders, es-
pecially those in the private sector, often speak quite dif-
ferent languages. Researchers need to be clear on what their 
goals are and communicate these in more readily under-
stood terms. This point is particularly important because 
it implies that the CHNRI exercises' research priorities that 
were identified as most likely to generate useful new knowl-
edge may not be considered equally relevant by the funders. 
This should certainly be taken into account when present-
ing and discussing the results of the CHNRI exercises.
Moreover, there seem to be important differences between 
the categories of funders in the criteria that they use to de-
cide on research priorities. Generally, all investors in health 
research are concerned with answerability of the proposed 
research ideas in an ethical way, feasibility and value for 
money. However, some may be particularly interested in 
potential for forming partnerships between researchers and 
industry to increase the translation of findings and their 
application. Ministries and international organizations ap-
peared more interested in deliverability, affordability and 
sustainability of the resulting interventions, local and na-
tional research capacities to carry out the proposed research 
ideas, and whether a research question is linked to an on-
going public debate or an important societal issue. Indus-
trial donors may be primarily motivated to generate patents 
and translate research results into commercial products. 
Finally, society as a whole may be more concerned with is-
sues of safety and equity issues and ask whether implemen-
tation of research results would widen the existing socio–
economic gaps..
Transparency of research priority setting processes must, 
therefore, begin with those who invest. Perceived returns 
on investments in health research should be clearly stated 
at the beginning of the process. They may be defined as re-
duction in disease burden wherever public money is being 
invested. Investors from industries may see patentable 
products as their preferred returns. Non–profit organiza-
tions may be primarily interested in increased media atten-
tion for their agenda. The context in which investment pri-
oritization takes place is thus primarily defined by 
expected returns of the funders. Moreover, their investment 
styles may be balanced and responsible (suggested for 
those investing public funds), risk–averting (which may be 
preferred among some industrial partners) or risk–seeking 
and biased towards high risk – high profit avenues of health 
research (which may be typical for some industry and not–
for–profit organizations).
Apart from funders’ perceived returns and their investment 
styles, the population, geographic area and disease burden 
of interest, the time frame in which returns are expected is 
an important defining component of the overall context. 
Priorities can differ substantially if the overall context is one 
of great urgency to tackle a problem, or whether decisions 
are made on very long–term, strategic investments.
CONCLUSIONS
The meeting with research funders organized by the WHO 
MNCAH department in March 2009 was exceptionally use-
ful in understanding that funders certainly have their own 
views on what represents an attractive funding option. 
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In March 2009, WHO officers invited 40 repre-
sentatives from organizations that provide 
substantial funding support for global child 
health research to take part in a consultation 
process at the WHO. The process aimed to ex-
plore funder's perspective in prioritization of 
health research. Eventually, 16 funders' repre-
sentatives agreed to take part in the exercise 
under the condition of anonymity. Participants 
agreed that the most relevant criteria for pri-
oritisation differed between researchers and 
funders. Funders are interested in clarity and 
specificity of research ideas, value for money, 
novelty, international competitiveness of the 
groups proposing the research, links to broad-
er societal issues, and complementarity with 
other long–term strategic investments that 
they have already made. Some may be partic-
ularly interested in the potential for forming 
partnerships between researchers and indus-
try to improve the translation of findings and 
their application
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Those views are not generalizable and may differ between 
categories of funders. Moreover, funders' perspectives are 
often quite different from those of researchers, or wider 
stakeholder groups. It is important to involve funders ear-
ly in the process of setting research priorities, such as the 
CHNRI process, to encourage their ownership of the re-
sults. Funder–supported criteria must be taken into ac-
count, in addition to those preferred by the researchers and 
wider stakeholders. Otherwise, the outcomes of research 
prioritization exercises may have very limited impact on 
funders' decision making.
The key value of the CHNRI method to funders lies in its 
ability to transparently lay out the potential risks and ben-
efits associated with investing in many competing research 
ideas, drawing on collective knowledge of the broad re-
search community. Results of the CHNRI process represent 
an attempt on the part of researchers to communicate their 
views and opinions to funders in a way that is easily un-
derstood, transparent, replicable and intuitive. It provides 
useful additional information that funders may, or may not 
take into account when deciding on their own research 
agenda. From a methodological perspective, finding ap-
propriate and effective ways of involving funders in future 
CHNRI exercises, communicating the outcomes clearly, 
and securing their commitment to acknowledge the results 
of the CHNRI process remain considerable challenges. An 
even greater challenge in future years will be to develop 
tools that can detect and evaluate the impact of CHNRI ex-
ercises on funder decision making and any change in fund-
ing priorities as a direct result of the CHNRI process. This 
should be particularly relevant to those who make decisions 
about investing public funds, whose primary agenda should 
be improving public health in the most cost–effective way – 
a target that CHNRI exercises should serve quite well.
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